Capital Senior Living Corporation
Capital Senior Living Corporation CSU Peers
See (CSU) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Care Facilities Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| CSU | $33.54 | -2.09% | 223.7M | 0.67 | $49.82 | N/A |
| HCA | $376.58 | -0.39% | 90.6B | 16.73 | $22.51 | +0.73% |
| FMS | $28.12 | -0.71% | 16.5B | 23.24 | $1.21 | +2.80% |
| THC | $171.50 | -0.42% | 15.9B | 11.01 | $15.58 | N/A |
| SOLV | $78.50 | +0.32% | 13.6B | 36.18 | $2.17 | N/A |
| EHC | $119.04 | +0.13% | 12B | 24.49 | $4.86 | +0.57% |
| UHS | $184.53 | +0.03% | 11.9B | 10.36 | $17.81 | +0.43% |
| DVA | $142.56 | +0.00% | 10.8B | 14.14 | $10.08 | N/A |
| OSH | $39.00 | +0.08% | 9.5B | -17.65 | -$2.21 | N/A |
| ENSG | $150.18 | +0.86% | 8.6B | 28.34 | $5.30 | +0.16% |
Stock Comparison
CSU vs HCA Comparison
CSU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CSU stands at 223.7M. In comparison, HCA has a market cap of 90.6B. Regarding current trading prices, CSU is priced at $33.54, while HCA trades at $376.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CSU currently has a P/E ratio of 0.67, whereas HCA's P/E ratio is 16.73. In terms of profitability, CSU's ROE is +2.23%, compared to HCA's ROE of -2.36%. Regarding short-term risk, CSU is more volatile compared to HCA. This indicates potentially higher risk in terms of short-term price fluctuations for CSU.
CSU vs FMS Comparison
CSU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CSU stands at 223.7M. In comparison, FMS has a market cap of 16.5B. Regarding current trading prices, CSU is priced at $33.54, while FMS trades at $28.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CSU currently has a P/E ratio of 0.67, whereas FMS's P/E ratio is 23.24. In terms of profitability, CSU's ROE is +2.23%, compared to FMS's ROE of +0.04%. Regarding short-term risk, CSU is more volatile compared to FMS. This indicates potentially higher risk in terms of short-term price fluctuations for CSU.
CSU vs THC Comparison
CSU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CSU stands at 223.7M. In comparison, THC has a market cap of 15.9B. Regarding current trading prices, CSU is priced at $33.54, while THC trades at $171.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CSU currently has a P/E ratio of 0.67, whereas THC's P/E ratio is 11.01. In terms of profitability, CSU's ROE is +2.23%, compared to THC's ROE of +0.37%. Regarding short-term risk, CSU is more volatile compared to THC. This indicates potentially higher risk in terms of short-term price fluctuations for CSU.
CSU vs SOLV Comparison
CSU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CSU stands at 223.7M. In comparison, SOLV has a market cap of 13.6B. Regarding current trading prices, CSU is priced at $33.54, while SOLV trades at $78.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CSU currently has a P/E ratio of 0.67, whereas SOLV's P/E ratio is 36.18. In terms of profitability, CSU's ROE is +2.23%, compared to SOLV's ROE of +0.12%. Regarding short-term risk, CSU is more volatile compared to SOLV. This indicates potentially higher risk in terms of short-term price fluctuations for CSU.
CSU vs EHC Comparison
CSU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CSU stands at 223.7M. In comparison, EHC has a market cap of 12B. Regarding current trading prices, CSU is priced at $33.54, while EHC trades at $119.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CSU currently has a P/E ratio of 0.67, whereas EHC's P/E ratio is 24.49. In terms of profitability, CSU's ROE is +2.23%, compared to EHC's ROE of +0.25%. Regarding short-term risk, CSU is more volatile compared to EHC. This indicates potentially higher risk in terms of short-term price fluctuations for CSU.
CSU vs UHS Comparison
CSU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CSU stands at 223.7M. In comparison, UHS has a market cap of 11.9B. Regarding current trading prices, CSU is priced at $33.54, while UHS trades at $184.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CSU currently has a P/E ratio of 0.67, whereas UHS's P/E ratio is 10.36. In terms of profitability, CSU's ROE is +2.23%, compared to UHS's ROE of +0.18%. Regarding short-term risk, CSU is more volatile compared to UHS. This indicates potentially higher risk in terms of short-term price fluctuations for CSU.
CSU vs DVA Comparison
CSU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CSU stands at 223.7M. In comparison, DVA has a market cap of 10.8B. Regarding current trading prices, CSU is priced at $33.54, while DVA trades at $142.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CSU currently has a P/E ratio of 0.67, whereas DVA's P/E ratio is 14.14. In terms of profitability, CSU's ROE is +2.23%, compared to DVA's ROE of +3.94%. Regarding short-term risk, CSU is more volatile compared to DVA. This indicates potentially higher risk in terms of short-term price fluctuations for CSU.
CSU vs OSH Comparison
CSU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CSU stands at 223.7M. In comparison, OSH has a market cap of 9.5B. Regarding current trading prices, CSU is priced at $33.54, while OSH trades at $39.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CSU currently has a P/E ratio of 0.67, whereas OSH's P/E ratio is -17.65. In terms of profitability, CSU's ROE is +2.23%, compared to OSH's ROE of +4.64%. Regarding short-term risk, CSU is more volatile compared to OSH. This indicates potentially higher risk in terms of short-term price fluctuations for CSU.
CSU vs ENSG Comparison
CSU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CSU stands at 223.7M. In comparison, ENSG has a market cap of 8.6B. Regarding current trading prices, CSU is priced at $33.54, while ENSG trades at $150.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CSU currently has a P/E ratio of 0.67, whereas ENSG's P/E ratio is 28.34. In terms of profitability, CSU's ROE is +2.23%, compared to ENSG's ROE of +0.17%. Regarding short-term risk, CSU is more volatile compared to ENSG. This indicates potentially higher risk in terms of short-term price fluctuations for CSU.
CSU vs CHE Comparison
CSU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CSU stands at 223.7M. In comparison, CHE has a market cap of 6.9B. Regarding current trading prices, CSU is priced at $33.54, while CHE trades at $473.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CSU currently has a P/E ratio of 0.67, whereas CHE's P/E ratio is 23.07. In terms of profitability, CSU's ROE is +2.23%, compared to CHE's ROE of +0.26%. Regarding short-term risk, CSU is more volatile compared to CHE. This indicates potentially higher risk in terms of short-term price fluctuations for CSU.
CSU vs LHCG Comparison
CSU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CSU stands at 223.7M. In comparison, LHCG has a market cap of 5.3B. Regarding current trading prices, CSU is priced at $33.54, while LHCG trades at $169.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CSU currently has a P/E ratio of 0.67, whereas LHCG's P/E ratio is 82.83. In terms of profitability, CSU's ROE is +2.23%, compared to LHCG's ROE of +0.04%. Regarding short-term risk, CSU is more volatile compared to LHCG. This indicates potentially higher risk in terms of short-term price fluctuations for CSU.
CSU vs OPCH Comparison
CSU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CSU stands at 223.7M. In comparison, OPCH has a market cap of 5.1B. Regarding current trading prices, CSU is priced at $33.54, while OPCH trades at $31.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CSU currently has a P/E ratio of 0.67, whereas OPCH's P/E ratio is 24.93. In terms of profitability, CSU's ROE is +2.23%, compared to OPCH's ROE of +0.15%. Regarding short-term risk, CSU is more volatile compared to OPCH. This indicates potentially higher risk in terms of short-term price fluctuations for CSU.
CSU vs AMED Comparison
CSU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CSU stands at 223.7M. In comparison, AMED has a market cap of 3.2B. Regarding current trading prices, CSU is priced at $33.54, while AMED trades at $96.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CSU currently has a P/E ratio of 0.67, whereas AMED's P/E ratio is 35.46. In terms of profitability, CSU's ROE is +2.23%, compared to AMED's ROE of +0.10%. Regarding short-term risk, CSU is more volatile compared to AMED. This indicates potentially higher risk in terms of short-term price fluctuations for CSU.
CSU vs SGRY Comparison
CSU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CSU stands at 223.7M. In comparison, SGRY has a market cap of 2.8B. Regarding current trading prices, CSU is priced at $33.54, while SGRY trades at $22.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CSU currently has a P/E ratio of 0.67, whereas SGRY's P/E ratio is -14.48. In terms of profitability, CSU's ROE is +2.23%, compared to SGRY's ROE of -0.10%. Regarding short-term risk, CSU is more volatile compared to SGRY. This indicates potentially higher risk in terms of short-term price fluctuations for CSU.
CSU vs ACHC Comparison
CSU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CSU stands at 223.7M. In comparison, ACHC has a market cap of 2.2B. Regarding current trading prices, CSU is priced at $33.54, while ACHC trades at $23.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CSU currently has a P/E ratio of 0.67, whereas ACHC's P/E ratio is 11.45. In terms of profitability, CSU's ROE is +2.23%, compared to ACHC's ROE of +0.06%. Regarding short-term risk, CSU is more volatile compared to ACHC. This indicates potentially higher risk in terms of short-term price fluctuations for CSU.
CSU vs ADUS Comparison
CSU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CSU stands at 223.7M. In comparison, ADUS has a market cap of 2.1B. Regarding current trading prices, CSU is priced at $33.54, while ADUS trades at $111.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CSU currently has a P/E ratio of 0.67, whereas ADUS's P/E ratio is 25.31. In terms of profitability, CSU's ROE is +2.23%, compared to ADUS's ROE of +0.08%. Regarding short-term risk, CSU is more volatile compared to ADUS. This indicates potentially higher risk in terms of short-term price fluctuations for CSU.
CSU vs SEM Comparison
CSU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CSU stands at 223.7M. In comparison, SEM has a market cap of 1.9B. Regarding current trading prices, CSU is priced at $33.54, while SEM trades at $15.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CSU currently has a P/E ratio of 0.67, whereas SEM's P/E ratio is 24.42. In terms of profitability, CSU's ROE is +2.23%, compared to SEM's ROE of +0.10%. Regarding short-term risk, CSU is more volatile compared to SEM. This indicates potentially higher risk in terms of short-term price fluctuations for CSU.
CSU vs ARDT Comparison
CSU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CSU stands at 223.7M. In comparison, ARDT has a market cap of 1.9B. Regarding current trading prices, CSU is priced at $33.54, while ARDT trades at $13.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CSU currently has a P/E ratio of 0.67, whereas ARDT's P/E ratio is 7.97. In terms of profitability, CSU's ROE is +2.23%, compared to ARDT's ROE of +0.24%. Regarding short-term risk, CSU is more volatile compared to ARDT. This indicates potentially higher risk in terms of short-term price fluctuations for CSU.
CSU vs LFST Comparison
CSU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CSU stands at 223.7M. In comparison, LFST has a market cap of 1.9B. Regarding current trading prices, CSU is priced at $33.54, while LFST trades at $4.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CSU currently has a P/E ratio of 0.67, whereas LFST's P/E ratio is -53.22. In terms of profitability, CSU's ROE is +2.23%, compared to LFST's ROE of -0.02%. Regarding short-term risk, CSU is more volatile compared to LFST. This indicates potentially higher risk in terms of short-term price fluctuations for CSU.
CSU vs AMEH Comparison
CSU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CSU stands at 223.7M. In comparison, AMEH has a market cap of 1.8B. Regarding current trading prices, CSU is priced at $33.54, while AMEH trades at $40.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CSU currently has a P/E ratio of 0.67, whereas AMEH's P/E ratio is 39.25. In terms of profitability, CSU's ROE is +2.23%, compared to AMEH's ROE of +0.07%. Regarding short-term risk, CSU is less volatile compared to AMEH. This indicates potentially lower risk in terms of short-term price fluctuations for CSU.
CSU vs NHC Comparison
CSU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CSU stands at 223.7M. In comparison, NHC has a market cap of 1.7B. Regarding current trading prices, CSU is priced at $33.54, while NHC trades at $108.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CSU currently has a P/E ratio of 0.67, whereas NHC's P/E ratio is 15.69. In terms of profitability, CSU's ROE is +2.23%, compared to NHC's ROE of +0.11%. Regarding short-term risk, CSU is more volatile compared to NHC. This indicates potentially higher risk in terms of short-term price fluctuations for CSU.
CSU vs BKD Comparison
CSU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CSU stands at 223.7M. In comparison, BKD has a market cap of 1.6B. Regarding current trading prices, CSU is priced at $33.54, while BKD trades at $6.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CSU currently has a P/E ratio of 0.67, whereas BKD's P/E ratio is -6.58. In terms of profitability, CSU's ROE is +2.23%, compared to BKD's ROE of -0.96%. Regarding short-term risk, CSU is more volatile compared to BKD. This indicates potentially higher risk in terms of short-term price fluctuations for CSU.
CSU vs ASTH Comparison
CSU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CSU stands at 223.7M. In comparison, ASTH has a market cap of 1.3B. Regarding current trading prices, CSU is priced at $33.54, while ASTH trades at $25.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CSU currently has a P/E ratio of 0.67, whereas ASTH's P/E ratio is 34.63. In terms of profitability, CSU's ROE is +2.23%, compared to ASTH's ROE of +0.07%. Regarding short-term risk, CSU is less volatile compared to ASTH. This indicates potentially lower risk in terms of short-term price fluctuations for CSU.
CSU vs USPH Comparison
CSU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CSU stands at 223.7M. In comparison, USPH has a market cap of 1.2B. Regarding current trading prices, CSU is priced at $33.54, while USPH trades at $82.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CSU currently has a P/E ratio of 0.67, whereas USPH's P/E ratio is 37.68. In terms of profitability, CSU's ROE is +2.23%, compared to USPH's ROE of +0.06%. Regarding short-term risk, CSU is more volatile compared to USPH. This indicates potentially higher risk in terms of short-term price fluctuations for CSU.
CSU vs BKDT Comparison
CSU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CSU stands at 223.7M. In comparison, BKDT has a market cap of 1.2B. Regarding current trading prices, CSU is priced at $33.54, while BKDT trades at $77.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CSU currently has a P/E ratio of 0.67, whereas BKDT's P/E ratio is N/A. In terms of profitability, CSU's ROE is +2.23%, compared to BKDT's ROE of -0.96%. Regarding short-term risk, CSU is more volatile compared to BKDT. This indicates potentially higher risk in terms of short-term price fluctuations for CSU.
CSU vs MD Comparison
CSU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CSU stands at 223.7M. In comparison, MD has a market cap of 1.2B. Regarding current trading prices, CSU is priced at $33.54, while MD trades at $13.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CSU currently has a P/E ratio of 0.67, whereas MD's P/E ratio is -13.78. In terms of profitability, CSU's ROE is +2.23%, compared to MD's ROE of -0.11%. Regarding short-term risk, CSU is more volatile compared to MD. This indicates potentially higher risk in terms of short-term price fluctuations for CSU.
CSU vs HCSG Comparison
CSU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CSU stands at 223.7M. In comparison, HCSG has a market cap of 1.1B. Regarding current trading prices, CSU is priced at $33.54, while HCSG trades at $15.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CSU currently has a P/E ratio of 0.67, whereas HCSG's P/E ratio is 27.53. In terms of profitability, CSU's ROE is +2.23%, compared to HCSG's ROE of +0.08%. Regarding short-term risk, CSU is more volatile compared to HCSG. This indicates potentially higher risk in terms of short-term price fluctuations for CSU.
CSU vs AGL Comparison
CSU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CSU stands at 223.7M. In comparison, AGL has a market cap of 1B. Regarding current trading prices, CSU is priced at $33.54, while AGL trades at $2.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CSU currently has a P/E ratio of 0.67, whereas AGL's P/E ratio is -3.92. In terms of profitability, CSU's ROE is +2.23%, compared to AGL's ROE of -0.44%. Regarding short-term risk, CSU is less volatile compared to AGL. This indicates potentially lower risk in terms of short-term price fluctuations for CSU.
CSU vs AVAH Comparison
CSU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CSU stands at 223.7M. In comparison, AVAH has a market cap of 907.2M. Regarding current trading prices, CSU is priced at $33.54, while AVAH trades at $4.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CSU currently has a P/E ratio of 0.67, whereas AVAH's P/E ratio is 155.00. In terms of profitability, CSU's ROE is +2.23%, compared to AVAH's ROE of -0.12%. Regarding short-term risk, CSU is less volatile compared to AVAH. This indicates potentially lower risk in terms of short-term price fluctuations for CSU.
CSU vs PNTG Comparison
CSU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CSU stands at 223.7M. In comparison, PNTG has a market cap of 906.5M. Regarding current trading prices, CSU is priced at $33.54, while PNTG trades at $26.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CSU currently has a P/E ratio of 0.67, whereas PNTG's P/E ratio is 34.61. In terms of profitability, CSU's ROE is +2.23%, compared to PNTG's ROE of +0.11%. Regarding short-term risk, CSU is more volatile compared to PNTG. This indicates potentially higher risk in terms of short-term price fluctuations for CSU.
CSU vs AMN Comparison
CSU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CSU stands at 223.7M. In comparison, AMN has a market cap of 839.2M. Regarding current trading prices, CSU is priced at $33.54, while AMN trades at $21.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CSU currently has a P/E ratio of 0.67, whereas AMN's P/E ratio is -5.06. In terms of profitability, CSU's ROE is +2.23%, compared to AMN's ROE of -0.21%. Regarding short-term risk, CSU is more volatile compared to AMN. This indicates potentially higher risk in terms of short-term price fluctuations for CSU.
CSU vs TALKW Comparison
CSU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CSU stands at 223.7M. In comparison, TALKW has a market cap of 687M. Regarding current trading prices, CSU is priced at $33.54, while TALKW trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CSU currently has a P/E ratio of 0.67, whereas TALKW's P/E ratio is N/A. In terms of profitability, CSU's ROE is +2.23%, compared to TALKW's ROE of -0.04%. Regarding short-term risk, CSU is less volatile compared to TALKW. This indicates potentially lower risk in terms of short-term price fluctuations for CSU.
CSU vs INNV Comparison
CSU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CSU stands at 223.7M. In comparison, INNV has a market cap of 602.2M. Regarding current trading prices, CSU is priced at $33.54, while INNV trades at $4.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CSU currently has a P/E ratio of 0.67, whereas INNV's P/E ratio is -18.58. In terms of profitability, CSU's ROE is +2.23%, compared to INNV's ROE of -0.12%. Regarding short-term risk, CSU is less volatile compared to INNV. This indicates potentially lower risk in terms of short-term price fluctuations for CSU.
CSU vs SNDA Comparison
CSU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CSU stands at 223.7M. In comparison, SNDA has a market cap of 480.5M. Regarding current trading prices, CSU is priced at $33.54, while SNDA trades at $25.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CSU currently has a P/E ratio of 0.67, whereas SNDA's P/E ratio is -7.02. In terms of profitability, CSU's ROE is +2.23%, compared to SNDA's ROE of -0.53%. Regarding short-term risk, CSU is more volatile compared to SNDA. This indicates potentially higher risk in terms of short-term price fluctuations for CSU.
CSU vs CYH Comparison
CSU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CSU stands at 223.7M. In comparison, CYH has a market cap of 478.4M. Regarding current trading prices, CSU is priced at $33.54, while CYH trades at $3.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CSU currently has a P/E ratio of 0.67, whereas CYH's P/E ratio is -0.93. In terms of profitability, CSU's ROE is +2.23%, compared to CYH's ROE of +0.30%. Regarding short-term risk, CSU is more volatile compared to CYH. This indicates potentially higher risk in terms of short-term price fluctuations for CSU.
CSU vs AUNA Comparison
CSU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CSU stands at 223.7M. In comparison, AUNA has a market cap of 468.5M. Regarding current trading prices, CSU is priced at $33.54, while AUNA trades at $6.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CSU currently has a P/E ratio of 0.67, whereas AUNA's P/E ratio is 9.74. In terms of profitability, CSU's ROE is +2.23%, compared to AUNA's ROE of +0.11%. Regarding short-term risk, CSU is more volatile compared to AUNA. This indicates potentially higher risk in terms of short-term price fluctuations for CSU.
CSU vs TALK Comparison
CSU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CSU stands at 223.7M. In comparison, TALK has a market cap of 463.5M. Regarding current trading prices, CSU is priced at $33.54, while TALK trades at $2.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CSU currently has a P/E ratio of 0.67, whereas TALK's P/E ratio is 138.50. In terms of profitability, CSU's ROE is +2.23%, compared to TALK's ROE of -0.04%. Regarding short-term risk, CSU is less volatile compared to TALK. This indicates potentially lower risk in terms of short-term price fluctuations for CSU.
CSU vs CCRN Comparison
CSU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CSU stands at 223.7M. In comparison, CCRN has a market cap of 426.5M. Regarding current trading prices, CSU is priced at $33.54, while CCRN trades at $13.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CSU currently has a P/E ratio of 0.67, whereas CCRN's P/E ratio is -24.09. In terms of profitability, CSU's ROE is +2.23%, compared to CCRN's ROE of -0.04%. Regarding short-term risk, CSU is more volatile compared to CCRN. This indicates potentially higher risk in terms of short-term price fluctuations for CSU.
CSU vs EHAB Comparison
CSU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CSU stands at 223.7M. In comparison, EHAB has a market cap of 387.4M. Regarding current trading prices, CSU is priced at $33.54, while EHAB trades at $7.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CSU currently has a P/E ratio of 0.67, whereas EHAB's P/E ratio is -2.76. In terms of profitability, CSU's ROE is +2.23%, compared to EHAB's ROE of -0.31%. Regarding short-term risk, CSU is more volatile compared to EHAB. This indicates potentially higher risk in terms of short-term price fluctuations for CSU.
CSU vs AONC Comparison
CSU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CSU stands at 223.7M. In comparison, AONC has a market cap of 379.5M. Regarding current trading prices, CSU is priced at $33.54, while AONC trades at $13.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CSU currently has a P/E ratio of 0.67, whereas AONC's P/E ratio is -14.62. In terms of profitability, CSU's ROE is +2.23%, compared to AONC's ROE of +0.25%. Regarding short-term risk, CSU is less volatile compared to AONC. This indicates potentially lower risk in terms of short-term price fluctuations for CSU.
CSU vs AIRS Comparison
CSU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CSU stands at 223.7M. In comparison, AIRS has a market cap of 337M. Regarding current trading prices, CSU is priced at $33.54, while AIRS trades at $5.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CSU currently has a P/E ratio of 0.67, whereas AIRS's P/E ratio is -18.62. In terms of profitability, CSU's ROE is +2.23%, compared to AIRS's ROE of -0.21%. Regarding short-term risk, CSU is less volatile compared to AIRS. This indicates potentially lower risk in terms of short-term price fluctuations for CSU.
CSU vs CMPS Comparison
CSU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CSU stands at 223.7M. In comparison, CMPS has a market cap of 302.7M. Regarding current trading prices, CSU is priced at $33.54, while CMPS trades at $3.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CSU currently has a P/E ratio of 0.67, whereas CMPS's P/E ratio is -1.64. In terms of profitability, CSU's ROE is +2.23%, compared to CMPS's ROE of -0.72%. Regarding short-term risk, CSU is less volatile compared to CMPS. This indicates potentially lower risk in terms of short-term price fluctuations for CSU.
CSU vs TOIIW Comparison
CSU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CSU stands at 223.7M. In comparison, TOIIW has a market cap of 276.7M. Regarding current trading prices, CSU is priced at $33.54, while TOIIW trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CSU currently has a P/E ratio of 0.67, whereas TOIIW's P/E ratio is N/A. In terms of profitability, CSU's ROE is +2.23%, compared to TOIIW's ROE of -4.83%. Regarding short-term risk, CSU is less volatile compared to TOIIW. This indicates potentially lower risk in terms of short-term price fluctuations for CSU.
CSU vs TOI Comparison
CSU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CSU stands at 223.7M. In comparison, TOI has a market cap of 231.6M. Regarding current trading prices, CSU is priced at $33.54, while TOI trades at $2.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CSU currently has a P/E ratio of 0.67, whereas TOI's P/E ratio is -3.60. In terms of profitability, CSU's ROE is +2.23%, compared to TOI's ROE of -4.83%. Regarding short-term risk, CSU is less volatile compared to TOI. This indicates potentially lower risk in terms of short-term price fluctuations for CSU.
CSU vs JYNT Comparison
CSU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CSU stands at 223.7M. In comparison, JYNT has a market cap of 178.9M. Regarding current trading prices, CSU is priced at $33.54, while JYNT trades at $11.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CSU currently has a P/E ratio of 0.67, whereas JYNT's P/E ratio is -116.90. In terms of profitability, CSU's ROE is +2.23%, compared to JYNT's ROE of -0.43%. Regarding short-term risk, CSU is more volatile compared to JYNT. This indicates potentially higher risk in terms of short-term price fluctuations for CSU.
CSU vs BTMD Comparison
CSU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CSU stands at 223.7M. In comparison, BTMD has a market cap of 161.6M. Regarding current trading prices, CSU is priced at $33.54, while BTMD trades at $4.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CSU currently has a P/E ratio of 0.67, whereas BTMD's P/E ratio is 7.28. In terms of profitability, CSU's ROE is +2.23%, compared to BTMD's ROE of -0.19%. Regarding short-term risk, CSU is more volatile compared to BTMD. This indicates potentially higher risk in terms of short-term price fluctuations for CSU.
CSU vs DCGO Comparison
CSU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CSU stands at 223.7M. In comparison, DCGO has a market cap of 156.6M. Regarding current trading prices, CSU is priced at $33.54, while DCGO trades at $1.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CSU currently has a P/E ratio of 0.67, whereas DCGO's P/E ratio is -158.00. In terms of profitability, CSU's ROE is +2.23%, compared to DCGO's ROE of -0.00%. Regarding short-term risk, CSU is less volatile compared to DCGO. This indicates potentially lower risk in terms of short-term price fluctuations for CSU.
CSU vs FVE Comparison
CSU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CSU stands at 223.7M. In comparison, FVE has a market cap of 98.4M. Regarding current trading prices, CSU is priced at $33.54, while FVE trades at $2.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CSU currently has a P/E ratio of 0.67, whereas FVE's P/E ratio is -5.64. In terms of profitability, CSU's ROE is +2.23%, compared to FVE's ROE of -0.15%. Regarding short-term risk, CSU is more volatile compared to FVE. This indicates potentially higher risk in terms of short-term price fluctuations for CSU.
CSU vs KDLYW Comparison
CSU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CSU stands at 223.7M. In comparison, KDLYW has a market cap of 96.5M. Regarding current trading prices, CSU is priced at $33.54, while KDLYW trades at $18.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CSU currently has a P/E ratio of 0.67, whereas KDLYW's P/E ratio is N/A. In terms of profitability, CSU's ROE is +2.23%, compared to KDLYW's ROE of -1.46%. Regarding short-term risk, CSU is less volatile compared to KDLYW. This indicates potentially lower risk in terms of short-term price fluctuations for CSU.
CSU vs MODV Comparison
CSU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CSU stands at 223.7M. In comparison, MODV has a market cap of 46.6M. Regarding current trading prices, CSU is priced at $33.54, while MODV trades at $3.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CSU currently has a P/E ratio of 0.67, whereas MODV's P/E ratio is -0.20. In terms of profitability, CSU's ROE is +2.23%, compared to MODV's ROE of +6.87%. Regarding short-term risk, CSU is less volatile compared to MODV. This indicates potentially lower risk in terms of short-term price fluctuations for CSU.
CSU vs ALR Comparison
CSU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CSU stands at 223.7M. In comparison, ALR has a market cap of 44.2M. Regarding current trading prices, CSU is priced at $33.54, while ALR trades at $1.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CSU currently has a P/E ratio of 0.67, whereas ALR's P/E ratio is -1.11. In terms of profitability, CSU's ROE is +2.23%, compared to ALR's ROE of -0.15%. Regarding short-term risk, CSU is more volatile compared to ALR. This indicates potentially higher risk in terms of short-term price fluctuations for CSU.
CSU vs CCEL Comparison
CSU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CSU stands at 223.7M. In comparison, CCEL has a market cap of 40.8M. Regarding current trading prices, CSU is priced at $33.54, while CCEL trades at $5.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CSU currently has a P/E ratio of 0.67, whereas CCEL's P/E ratio is 505.00. In terms of profitability, CSU's ROE is +2.23%, compared to CCEL's ROE of -0.01%. Regarding short-term risk, CSU is more volatile compared to CCEL. This indicates potentially higher risk in terms of short-term price fluctuations for CSU.
CSU vs IMAC Comparison
CSU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CSU stands at 223.7M. In comparison, IMAC has a market cap of 33.1M. Regarding current trading prices, CSU is priced at $33.54, while IMAC trades at $1.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CSU currently has a P/E ratio of 0.67, whereas IMAC's P/E ratio is -2.27. In terms of profitability, CSU's ROE is +2.23%, compared to IMAC's ROE of +2.46%. Regarding short-term risk, CSU is more volatile compared to IMAC. This indicates potentially higher risk in terms of short-term price fluctuations for CSU.
CSU vs PIII Comparison
CSU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CSU stands at 223.7M. In comparison, PIII has a market cap of 20.9M. Regarding current trading prices, CSU is priced at $33.54, while PIII trades at $6.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CSU currently has a P/E ratio of 0.67, whereas PIII's P/E ratio is -0.12. In terms of profitability, CSU's ROE is +2.23%, compared to PIII's ROE of -1.29%. Regarding short-term risk, CSU is more volatile compared to PIII. This indicates potentially higher risk in terms of short-term price fluctuations for CSU.
CSU vs AMS Comparison
CSU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CSU stands at 223.7M. In comparison, AMS has a market cap of 16.1M. Regarding current trading prices, CSU is priced at $33.54, while AMS trades at $2.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CSU currently has a P/E ratio of 0.67, whereas AMS's P/E ratio is 11.86. In terms of profitability, CSU's ROE is +2.23%, compared to AMS's ROE of +0.06%. Regarding short-term risk, CSU is less volatile compared to AMS. This indicates potentially lower risk in terms of short-term price fluctuations for CSU.
CSU vs AIH Comparison
CSU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CSU stands at 223.7M. In comparison, AIH has a market cap of 15.9M. Regarding current trading prices, CSU is priced at $33.54, while AIH trades at $0.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CSU currently has a P/E ratio of 0.67, whereas AIH's P/E ratio is -2.78. In terms of profitability, CSU's ROE is +2.23%, compared to AIH's ROE of +1.16%. Regarding short-term risk, CSU is less volatile compared to AIH. This indicates potentially lower risk in terms of short-term price fluctuations for CSU.
CSU vs CANO Comparison
CSU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CSU stands at 223.7M. In comparison, CANO has a market cap of 12.4M. Regarding current trading prices, CSU is priced at $33.54, while CANO trades at $2.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CSU currently has a P/E ratio of 0.67, whereas CANO's P/E ratio is -0.01. In terms of profitability, CSU's ROE is +2.23%, compared to CANO's ROE of -1.49%. Regarding short-term risk, CSU is less volatile compared to CANO. This indicates potentially lower risk in terms of short-term price fluctuations for CSU.
CSU vs FTRP Comparison
CSU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CSU stands at 223.7M. In comparison, FTRP has a market cap of 9.8M. Regarding current trading prices, CSU is priced at $33.54, while FTRP trades at $0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CSU currently has a P/E ratio of 0.67, whereas FTRP's P/E ratio is -1.22. In terms of profitability, CSU's ROE is +2.23%, compared to FTRP's ROE of -0.62%. Regarding short-term risk, CSU is more volatile compared to FTRP. This indicates potentially higher risk in terms of short-term price fluctuations for CSU.
CSU vs NIVFW Comparison
CSU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CSU stands at 223.7M. In comparison, NIVFW has a market cap of 5.8M. Regarding current trading prices, CSU is priced at $33.54, while NIVFW trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CSU currently has a P/E ratio of 0.67, whereas NIVFW's P/E ratio is N/A. In terms of profitability, CSU's ROE is +2.23%, compared to NIVFW's ROE of -0.39%. Regarding short-term risk, CSU is less volatile compared to NIVFW. This indicates potentially lower risk in terms of short-term price fluctuations for CSU.
CSU vs GBNH Comparison
CSU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CSU stands at 223.7M. In comparison, GBNH has a market cap of 5.5M. Regarding current trading prices, CSU is priced at $33.54, while GBNH trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CSU currently has a P/E ratio of 0.67, whereas GBNH's P/E ratio is -0.06. In terms of profitability, CSU's ROE is +2.23%, compared to GBNH's ROE of +15.74%. Regarding short-term risk, CSU is less volatile compared to GBNH. This indicates potentially lower risk in terms of short-term price fluctuations for CSU.
CSU vs RHE Comparison
CSU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CSU stands at 223.7M. In comparison, RHE has a market cap of 5.2M. Regarding current trading prices, CSU is priced at $33.54, while RHE trades at $2.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CSU currently has a P/E ratio of 0.67, whereas RHE's P/E ratio is -1.79. In terms of profitability, CSU's ROE is +2.23%, compared to RHE's ROE of +1.52%. Regarding short-term risk, CSU is less volatile compared to RHE. This indicates potentially lower risk in terms of short-term price fluctuations for CSU.
CSU vs MNDR Comparison
CSU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CSU stands at 223.7M. In comparison, MNDR has a market cap of 4.8M. Regarding current trading prices, CSU is priced at $33.54, while MNDR trades at $1.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CSU currently has a P/E ratio of 0.67, whereas MNDR's P/E ratio is -0.16. In terms of profitability, CSU's ROE is +2.23%, compared to MNDR's ROE of -5.70%. Regarding short-term risk, CSU is less volatile compared to MNDR. This indicates potentially lower risk in terms of short-term price fluctuations for CSU.
CSU vs ATIP Comparison
CSU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CSU stands at 223.7M. In comparison, ATIP has a market cap of 4.4M. Regarding current trading prices, CSU is priced at $33.54, while ATIP trades at $0.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CSU currently has a P/E ratio of 0.67, whereas ATIP's P/E ratio is -0.05. In terms of profitability, CSU's ROE is +2.23%, compared to ATIP's ROE of +1.77%. Regarding short-term risk, CSU is less volatile compared to ATIP. This indicates potentially lower risk in terms of short-term price fluctuations for CSU.
CSU vs IMACW Comparison
CSU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CSU stands at 223.7M. In comparison, IMACW has a market cap of 1.7M. Regarding current trading prices, CSU is priced at $33.54, while IMACW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CSU currently has a P/E ratio of 0.67, whereas IMACW's P/E ratio is N/A. In terms of profitability, CSU's ROE is +2.23%, compared to IMACW's ROE of +2.46%. Regarding short-term risk, CSU is less volatile compared to IMACW. This indicates potentially lower risk in terms of short-term price fluctuations for CSU.
CSU vs SYRA Comparison
CSU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CSU stands at 223.7M. In comparison, SYRA has a market cap of 1.1M. Regarding current trading prices, CSU is priced at $33.54, while SYRA trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CSU currently has a P/E ratio of 0.67, whereas SYRA's P/E ratio is -0.30. In terms of profitability, CSU's ROE is +2.23%, compared to SYRA's ROE of -1.04%. Regarding short-term risk, CSU is less volatile compared to SYRA. This indicates potentially lower risk in terms of short-term price fluctuations for CSU.
CSU vs CCM Comparison
CSU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CSU stands at 223.7M. In comparison, CCM has a market cap of 823.9K. Regarding current trading prices, CSU is priced at $33.54, while CCM trades at $5.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CSU currently has a P/E ratio of 0.67, whereas CCM's P/E ratio is -0.57. In terms of profitability, CSU's ROE is +2.23%, compared to CCM's ROE of +0.08%. Regarding short-term risk, CSU is more volatile compared to CCM. This indicates potentially higher risk in terms of short-term price fluctuations for CSU.
CSU vs RHE-PA Comparison
CSU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CSU stands at 223.7M. In comparison, RHE-PA has a market cap of 674.5K. Regarding current trading prices, CSU is priced at $33.54, while RHE-PA trades at $0.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CSU currently has a P/E ratio of 0.67, whereas RHE-PA's P/E ratio is -0.09. In terms of profitability, CSU's ROE is +2.23%, compared to RHE-PA's ROE of +1.52%. Regarding short-term risk, CSU is less volatile compared to RHE-PA. This indicates potentially lower risk in terms of short-term price fluctuations for CSU.
CSU vs BACK Comparison
CSU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CSU stands at 223.7M. In comparison, BACK has a market cap of 189.2K. Regarding current trading prices, CSU is priced at $33.54, while BACK trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CSU currently has a P/E ratio of 0.67, whereas BACK's P/E ratio is -0.01. In terms of profitability, CSU's ROE is +2.23%, compared to BACK's ROE of +2.46%. Regarding short-term risk, CSU is more volatile compared to BACK. This indicates potentially higher risk in terms of short-term price fluctuations for CSU.
CSU vs IONM Comparison
CSU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CSU stands at 223.7M. In comparison, IONM has a market cap of 90.9K. Regarding current trading prices, CSU is priced at $33.54, while IONM trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CSU currently has a P/E ratio of 0.67, whereas IONM's P/E ratio is N/A. In terms of profitability, CSU's ROE is +2.23%, compared to IONM's ROE of +0.75%. Regarding short-term risk, CSU is less volatile compared to IONM. This indicates potentially lower risk in terms of short-term price fluctuations for CSU.
CSU vs PIIIW Comparison
CSU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CSU stands at 223.7M. In comparison, PIIIW has a market cap of 38.9K. Regarding current trading prices, CSU is priced at $33.54, while PIIIW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CSU currently has a P/E ratio of 0.67, whereas PIIIW's P/E ratio is -0.01. In terms of profitability, CSU's ROE is +2.23%, compared to PIIIW's ROE of -1.29%. Regarding short-term risk, CSU is less volatile compared to PIIIW. This indicates potentially lower risk in terms of short-term price fluctuations for CSU.
CSU vs NVOS Comparison
CSU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CSU stands at 223.7M. In comparison, NVOS has a market cap of 5.9K. Regarding current trading prices, CSU is priced at $33.54, while NVOS trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CSU currently has a P/E ratio of 0.67, whereas NVOS's P/E ratio is N/A. In terms of profitability, CSU's ROE is +2.23%, compared to NVOS's ROE of -1.20%. Regarding short-term risk, CSU is more volatile compared to NVOS. This indicates potentially higher risk in terms of short-term price fluctuations for CSU.
CSU vs DCGOW Comparison
CSU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CSU stands at 223.7M. In comparison, DCGOW has a market cap of 0. Regarding current trading prices, CSU is priced at $33.54, while DCGOW trades at $1.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CSU currently has a P/E ratio of 0.67, whereas DCGOW's P/E ratio is N/A. In terms of profitability, CSU's ROE is +2.23%, compared to DCGOW's ROE of -0.00%. Regarding short-term risk, CSU is less volatile compared to DCGOW. This indicates potentially lower risk in terms of short-term price fluctuations for CSU.
CSU vs HNGR Comparison
CSU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CSU stands at 223.7M. In comparison, HNGR has a market cap of 0. Regarding current trading prices, CSU is priced at $33.54, while HNGR trades at $18.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CSU currently has a P/E ratio of 0.67, whereas HNGR's P/E ratio is 19.71. In terms of profitability, CSU's ROE is +2.23%, compared to HNGR's ROE of +0.52%. Regarding short-term risk, CSU is more volatile compared to HNGR. This indicates potentially higher risk in terms of short-term price fluctuations for CSU.
CSU vs TLMDW Comparison
CSU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CSU stands at 223.7M. In comparison, TLMDW has a market cap of 0. Regarding current trading prices, CSU is priced at $33.54, while TLMDW trades at $0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CSU currently has a P/E ratio of 0.67, whereas TLMDW's P/E ratio is N/A. In terms of profitability, CSU's ROE is +2.23%, compared to TLMDW's ROE of -0.46%. Regarding short-term risk, CSU is less volatile compared to TLMDW. This indicates potentially lower risk in terms of short-term price fluctuations for CSU.
CSU vs TVTY Comparison
CSU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CSU stands at 223.7M. In comparison, TVTY has a market cap of 0. Regarding current trading prices, CSU is priced at $33.54, while TVTY trades at $32.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CSU currently has a P/E ratio of 0.67, whereas TVTY's P/E ratio is 19.06. In terms of profitability, CSU's ROE is +2.23%, compared to TVTY's ROE of +1.75%. Regarding short-term risk, CSU is more volatile compared to TVTY. This indicates potentially higher risk in terms of short-term price fluctuations for CSU.
CSU vs NFH Comparison
CSU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CSU stands at 223.7M. In comparison, NFH has a market cap of 0. Regarding current trading prices, CSU is priced at $33.54, while NFH trades at $11.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CSU currently has a P/E ratio of 0.67, whereas NFH's P/E ratio is -19.75. In terms of profitability, CSU's ROE is +2.23%, compared to NFH's ROE of -0.06%. Regarding short-term risk, CSU is more volatile compared to NFH. This indicates potentially higher risk in terms of short-term price fluctuations for CSU.
CSU vs DVCR Comparison
CSU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CSU stands at 223.7M. In comparison, DVCR has a market cap of 0. Regarding current trading prices, CSU is priced at $33.54, while DVCR trades at $10.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CSU currently has a P/E ratio of 0.67, whereas DVCR's P/E ratio is 28.34. In terms of profitability, CSU's ROE is +2.23%, compared to DVCR's ROE of -0.15%. Regarding short-term risk, CSU is more volatile compared to DVCR. This indicates potentially higher risk in terms of short-term price fluctuations for CSU.
CSU vs TLMD Comparison
CSU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CSU stands at 223.7M. In comparison, TLMD has a market cap of 0. Regarding current trading prices, CSU is priced at $33.54, while TLMD trades at $3.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CSU currently has a P/E ratio of 0.67, whereas TLMD's P/E ratio is -1.60. In terms of profitability, CSU's ROE is +2.23%, compared to TLMD's ROE of -0.46%. Regarding short-term risk, CSU is more volatile compared to TLMD. This indicates potentially higher risk in terms of short-term price fluctuations for CSU.
CSU vs SLHGP Comparison
CSU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CSU stands at 223.7M. In comparison, SLHGP has a market cap of 0. Regarding current trading prices, CSU is priced at $33.54, while SLHGP trades at $12.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CSU currently has a P/E ratio of 0.67, whereas SLHGP's P/E ratio is -30.38. In terms of profitability, CSU's ROE is +2.23%, compared to SLHGP's ROE of -0.71%. Regarding short-term risk, CSU is more volatile compared to SLHGP. This indicates potentially higher risk in terms of short-term price fluctuations for CSU.
CSU vs SLHG Comparison
CSU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CSU stands at 223.7M. In comparison, SLHG has a market cap of 0. Regarding current trading prices, CSU is priced at $33.54, while SLHG trades at $0.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CSU currently has a P/E ratio of 0.67, whereas SLHG's P/E ratio is -1.48. In terms of profitability, CSU's ROE is +2.23%, compared to SLHG's ROE of N/A. Regarding short-term risk, CSU is less volatile compared to SLHG. This indicates potentially lower risk in terms of short-term price fluctuations for CSU.